PolyPid to potentially receive over $110 million in upfront and milestone payments as well as royalties on net…
Holly Emerton08/08/2022
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the European Commission…
Holly Emerton28/07/2022
Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of drug-resistant…
Holly Emerton25/07/2022
Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that…
Holly Emerton22/07/2022
PolyPid Ltd. , a late-stage biopharma company aiming to improve surgical outcomes, announced today that…
Holly Emerton06/04/2022
VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for…
Holly Emerton04/04/2022
"It was magical. You feel like you're doing something that will alter for the better…
Holly Emerton09/02/2022
Numan provides men with direct online access to medical professionals, prescription medication, at-home blood testing, and…
Holly Emerton09/02/2022
Scandit, the global leader in smart data capture, has completed a Series D funding round…
Holly Emerton09/02/2022
ProQR Therapeutics N.V. a company dedicated to changing lives through the creation of transformative RNA…
Holly Emerton04/01/2022
AMRA Medical, a ground-breaking digital health company and global leader in body composition analysis offering…
Ben (Reactive)21/12/2021
Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a…
Holly Emerton23/11/2021
Subscribe to our mailing list
Get our newsletter, Kreos updates and information on our events right to your mailbox.
